{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T03:11:30Z","timestamp":1710126690213},"reference-count":59,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1097\/maj.0b013e3180cab70a","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T01:34:14Z","timestamp":1236216854000},"page":"356-360","source":"Crossref","is-referenced-by-count":8,"title":["Benzene Exposure and Refractory Sideroblastic Erythropoiesis: Is There an Association?"],"prefix":"10.1016","volume":"334","author":[{"given":"Ethan A.","family":"Natelson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1097\/MAJ.0b013e3180cab70a_bb0010","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.blre.2005.01.004","article-title":"Myelodysplasic (sic) syndromes: a comprehensive review","volume":"19","author":"Catenacci","year":"2005","journal-title":"Blood Rev"},{"key":"10.1097\/MAJ.0b013e3180cab70a_bb0015","first-page":"1","article-title":"Myelodysplastic syndromes (MDS): what is new?","volume":"11","author":"Kantarjian","year":"2006","journal-title":"Leukemia Insights"},{"key":"10.1097\/MAJ.0b013e3180cab70a_bb0020","first-page":"71","article-title":"Pathogenesis, etiology and epidemiology of myelodysplastic syndromes","volume":"83","author":"Aul","year":"1998","journal-title":"Haematol"},{"key":"10.1097\/MAJ.0b013e3180cab70a_bb0025","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1056\/NEJMp048266","article-title":"Myelodysplastic syndromes: coping with ineffective hematopoiesis","volume":"352","author":"Cazzola","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1097\/MAJ.0b013e3180cab70a_bb0030","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1056\/NEJM199905273402107","article-title":"Myelodysplasia","volume":"340","author":"Heaney","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1097\/MAJ.0b013e3180cab70a_bb0035","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.leukres.2005.01.003","article-title":"Myelodysplastic syndromes in patients under 50 years old: a single institution experience","volume":"29","author":"Breccia","year":"2005","journal-title":"Leuk Res"},{"key":"10.1097\/MAJ.0b013e3180cab70a_bb0040","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1038\/sj.leu.2403945","article-title":"EH Risk factors of myelodysplastic syndrome: a case control study","volume":"19","author":"Strom","year":"2005","journal-title":"Leukemia"},{"key":"10.1097\/MAJ.0b013e3180cab70a_bb0045","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1093\/jnci\/89.14.1065","article-title":"Benzene and the dose-related incidence of hematologic neoplasms in China","volume":"89","author":"Hayes","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"10.1097\/MAJ.0b013e3180cab70a_bb0050","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/S0140-6736(06)69780-8","article-title":"Acute myeloid leukaemia","volume":"368","author":"Estey","year":"2006","journal-title":"Lancet"},{"key":"10.1097\/MAJ.0b013e3180cab70a_bb0055","doi-asserted-by":"crossref","first-page":"7594","DOI":"10.1200\/JCO.2005.01.7038","article-title":"Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making","volume":"23","author":"Malcovati","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1097\/MAJ.0b013e3180cab70a_bb0060","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s00277-005-0030-z","article-title":"Comparison of five prognostic scoring systems, the French-American-British (FAB) and World Health Organization (WHO) classifications in patients with myelodysplastic syndromes: results of a single-center analysis","volume":"85","author":"M\u00fcller-Berndorff","year":"2006","journal-title":"Ann Hematol"},{"key":"10.1097\/MAJ.0b013e3180cab70a_bb0065","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00005792-197105000-00001","article-title":"Idiopathic refractory sideroblastic anemia: clinical and laboratory investigation of 17 patients and review of the literature","volume":"50","author":"Kushner","year":"1971","journal-title":"Medicine"},{"key":"10.1097\/MAJ.0b013e3180cab70a_bb0070","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/1097-0142(197908)44:2<724::AID-CNCR2820440245>3.0.CO;2-W","article-title":"Idiopathic refractory sideroblastic anemia: incidence and risk factors for leukemic transformation","volume":"44","author":"Cheng","year":"1979","journal-title":"Cancer"},{"key":"10.1097\/MAJ.0b013e3180cab70a_bb0075","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1182\/blood.V71.2.305.305","article-title":"Natural history of idiopathic refractory sideroblastic anemia","volume":"71","author":"Cazzola","year":"1988","journal-title":"Blood"},{"key":"10.1097\/MAJ.0b013e3180cab70a_bb0080","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1365-2141.1965.tb00084.x","article-title":"Sideroblastic anaemia: is this a malignancy?","volume":"11","author":"Dameshek","year":"1965","journal-title":"Br J Haematol"},{"key":"10.1097\/MAJ.0b013e3180cab70a_bb0085","doi-asserted-by":"crossref","first-page":"60","DOI":"10.7326\/0003-4819-48-1-60","article-title":"A comparison of the plasma iron, iron-binding capacity, sternal marrow iron and other methods in the clinical evaluation of iron stores","volume":"48","author":"Beutler","year":"1958","journal-title":"Ann Intern Med"},{"key":"10.1097\/MAJ.0b013e3180cab70a_bb0090","doi-asserted-by":"crossref","first-page":"5358","DOI":"10.1200\/JCO.2006.07.5598","article-title":"Myelodysplastic syndromes in patients younger than age 50","volume":"24","author":"Kuendgen","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1097\/MAJ.0b013e3180cab70a_bb0095","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1001\/archinte.1988.00380030159026","article-title":"Ringed sideroblasts in primary myelodysplasia: leukemic propensity and prognostic factors","volume":"148","author":"Vandermolen","year":"1988","journal-title":"Ann Intern Med"},{"key":"10.1097\/MAJ.0b013e3180cab70a_bb0100","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/0145-2126(92)90171-3","article-title":"Heterogeneity of acquired idiopathic sideroblastic anaemia (AISA)","volume":"16","author":"Garand","year":"1992","journal-title":"Leukemia Res"},{"key":"10.1097\/MAJ.0b013e3180cab70a_bb0105","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1046\/j.1365-2141.2000.01940.x","article-title":"Two types of acquired idiopathic sideroblastic anaemia (AlSA): a time tested distinction","volume":"108","author":"Germing","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1097\/MAJ.0b013e3180cab70a_bb0110","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0165-4608(86)90058-0","article-title":"Chromosome abnormalities in acquired idiopathic sideroblastic anemia with subsequent leukemic transformation","volume":"19","author":"Schwartz","year":"1986","journal-title":"Can Gen Cytogenet"},{"key":"10.1097\/MAJ.0b013e3180cab70a_bb0115","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.leukres.2006.10.023","article-title":"Evaluation of recurring cytogenetic abnormalities in the treatment of myelodysplastic syndromes","volume":"31","author":"Olney","year":"2007","journal-title":"Leuk Res"},{"key":"10.1097\/MAJ.0b013e3180cab70a_bb0120","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1093\/ajcp\/106.5.680","article-title":"Hematologic disorders associated with deletions of chromosome 20q: a clinicopathologic study of 107 patients","volume":"106","author":"Kurtin","year":"1996","journal-title":"Am J Clin Pathol"},{"key":"10.1097\/MAJ.0b013e3180cab70a_bb0125","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.leukres.2004.07.014","article-title":"A retrospective analysis of myelodysplastic syndromes with thrombocytosis: reclassification of the cases by WHO proposals","volume":"29","author":"Cabello","year":"2005","journal-title":"Leuk Res"},{"key":"10.1097\/MAJ.0b013e3180cab70a_bb0130","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1365-2141.2005.05747.x","article-title":"Ringed sideroblasts with thrombocytosis: an uncommon mixed myelodysplastic\/myeloproliferative disease of older adults","volume":"31","author":"Shaw","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1097\/MAJ.0b013e3180cab70a_bb0135","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1182\/blood-2006-02-005751","article-title":"Refractory anemia with ringed sideroblasts associated with marked thrombocytosis (RARS-T), another myeloproliferative condition characterized by JAK2 V617F mutation","author":"Szpurka","year":"2006","journal-title":"Blood"},{"key":"10.1097\/MAJ.0b013e3180cab70a_bb0140","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1182\/blood-2006-03-008227","article-title":"The JAK2-V61F mutation and essential thrombocythemia features in a subset of patients with refractory anemia with ring sideroblasts (RARS)","volume":"108","author":"Boissinot","year":"2006","journal-title":"Blood"},{"key":"10.1097\/MAJ.0b013e3180cab70a_bb0145","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1055\/s-2006-942755","article-title":"New insights into the pathogenesis of JAK2 V617F-positive myeloproliferative disorders and consequences for the management of patients","volume":"32","author":"Villeval","year":"2006","journal-title":"Semin Thromb Haemost"},{"key":"10.1097\/MAJ.0b013e3180cab70a_bb0150","first-page":"1137","article-title":"BU Weekly Clinicopathologial Exercises (case 17-1992)","volume":"326","author":"Scully","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1097\/MAJ.0b013e3180cab70a_bb0155","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1200\/JCO.2006.08.5696","article-title":"Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes","volume":"25","author":"Malcovati","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1097\/MAJ.0b013e3180cab70a_bb0160","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1182\/blood.V44.1.117.117","article-title":"Sideroblastic anemia treated with immunosuppressive therapy","volume":"44","author":"Zervas","year":"1974","journal-title":"Blood"},{"key":"10.1097\/MAJ.0b013e3180cab70a_bb0165","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s00277-002-0539-3","article-title":"Myelodysplastic syndrome complicated by autoimmune hemolytic anemia: remission of refractory anemia following mycophenolate mofetil","volume":"81","author":"Lin","year":"2002","journal-title":"Ann Hematol"},{"key":"10.1097\/MAJ.0b013e3180cab70a_bb0170","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/00000441-200610000-00008","article-title":"Pregnancy-induced pancytopenia: distinctive hematological features","volume":"332","author":"Natelson","year":"2006","journal-title":"Am J Med Sci"},{"key":"10.1097\/MAJ.0b013e3180cab70a_bb0175","doi-asserted-by":"crossref","DOI":"10.1002\/ajh.20864","article-title":"Copper deficiency causes reversible myelodysplasia","volume":"82","author":"Huff","year":"2007","journal-title":"Am J Hematol"},{"key":"10.1097\/MAJ.0b013e3180cab70a_bb0180","doi-asserted-by":"crossref","first-page":"625","DOI":"10.7326\/0003-4819-92-5-625","article-title":"Sideroblastic Anemia as a preleukemic event in patients treated for Hodgkin\u2019s disease","volume":"92","author":"Kitahara","year":"1980","journal-title":"Ann Intern Med"},{"key":"10.1097\/MAJ.0b013e3180cab70a_bb0185","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/sj.leu.2401613","article-title":"Sideroblastic anemia following treatment of chronic myeloid leukemia with busulfan","volume":"14","author":"Magalh\u00e3es","year":"2002","journal-title":"Leukemia"},{"key":"10.1097\/MAJ.0b013e3180cab70a_bb0190","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/ajh.2830280316","article-title":"Busulfan-induced sideroblastic anemia","volume":"28","author":"Fernandez","year":"1998","journal-title":"Am J Hematol"},{"key":"10.1097\/MAJ.0b013e3180cab70a_bb0195","first-page":"1353","article-title":"Clinical features of hematopoietic malignancies and related disorders among benzene exposed workers in china","volume":"104","author":"Linet","year":"1996","journal-title":"Environ Health Perspect"},{"key":"10.1097\/MAJ.0b013e3180cab70a_bb0200","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0013-9351(80)90104-8","article-title":"Different types of malignancies due to occupational exposure to benzene: a review of recent observations in Turkey","volume":"23","author":"Aksoy","year":"1980","journal-title":"Environ Res"},{"key":"10.1097\/MAJ.0b013e3180cab70a_bb0205","first-page":"296","article-title":"Haematological effects of chronic benzene poisoning in 217 workers","volume":"28","author":"Aksoy","year":"1971","journal-title":"Br J Indust Med"},{"key":"10.1097\/MAJ.0b013e3180cab70a_bb0210","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/ajim.10138","article-title":"Benzene exposure and hematopoietic mortality: a long-term epidemiologic risk assessment","volume":"42","author":"Rinsky","year":"2002","journal-title":"Am J Indust Med"},{"key":"10.1097\/MAJ.0b013e3180cab70a_bb0215","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.leukres.2005.08.019","article-title":"Chronic exposure to benzene results in a unique form of dysplasia","volume":"29","author":"Irons","year":"2005","journal-title":"Leukemia Res"},{"key":"10.1097\/MAJ.0b013e3180cab70a_bb0220","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0344-0338(11)80705-3","article-title":"Bone marrow morphology in patients with neutropenia due to chronic exposure to organic solvents (benzene): early lesions","volume":"190","author":"Ruiz","year":"1994","journal-title":"Path Res Pract"},{"key":"10.1097\/MAJ.0b013e3180cab70a_bb0225","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000101709","article-title":"Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes and myelodysplastic\/myeloproliferative diseases","volume":"74","author":"Orazi","year":"2007","journal-title":"Pathobid"},{"key":"10.1097\/MAJ.0b013e3180cab70a_bb0230","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00001648-200005000-00010","article-title":"Smoking and myelodysplastic syndromes","volume":"11","author":"Bj\u00f6rk","year":"2000","journal-title":"Epidemiol"},{"key":"10.1097\/MAJ.0b013e3180cab70a_bb0235","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1046\/j.1365-2141.1997.942910.x","article-title":"Tobacco smoking and risk of haematological malignancies in adults: a case-control study","volume":"97","author":"Pasqualetti","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1097\/MAJ.0b013e3180cab70a_bb0240","unstructured":"Carmona R. The Surgeon General\u2019s 2004 report, The Health Consequences of Smoking. US Dept Health and Human Services, Chap 2, p 254"},{"key":"10.1097\/MAJ.0b013e3180cab70a_bb0245","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1093\/annonc\/mdf269","article-title":"Influence of cigarette smoking on the presentation and course of acute myeloid leukemia","volume":"13","author":"Chelghoum","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1097\/MAJ.0b013e3180cab70a_bb0250","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/sj.leu.2404698","article-title":"Cigarette smoking, cytogenetic abnormalities, and acute myelogenous leukemia","volume":"21","author":"Lichtman","year":"2007","journal-title":"Leuk"},{"key":"10.1097\/MAJ.0b013e3180cab70a_bb0255","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1080\/10428190310001638904","article-title":"Cigarette smoking and acute leukemia","volume":"45","author":"Thomas","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"10.1097\/MAJ.0b013e3180cab70a_bb0260","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1038\/sj.bjc.6690833","article-title":"Tobacco and the risk of acute leukaemia in adults","volume":"81","author":"Kane","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1097\/MAJ.0b013e3180cab70a_bb0265","first-page":"1123","article-title":"Chromosome 8, occupational exposures, smoking, and acute nonlymphocytic leukemias: a population-based study","volume":"7","author":"Davico","year":"1998","journal-title":"Can Epidemiol Biomarkers Prev"},{"key":"10.1097\/MAJ.0b013e3180cab70a_bb0270","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/sj.bjc.6600010","article-title":"Smoking and the risk of acute myeloid leukaemia in cytogenetic subgroups","volume":"86","author":"Moorman","year":"2002","journal-title":"Br J Cancer"},{"key":"10.1097\/MAJ.0b013e3180cab70a_bb0275","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/jnci\/88.7.407","article-title":"The secondary leukemias: challenges and research directions","volume":"88","author":"Smith","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"10.1097\/MAJ.0b013e3180cab70a_bb0280","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cbi.2005.03.025","article-title":"Benzene and the hematopoietic stem cell","volume":"153-154","author":"Morgan","year":"2005","journal-title":"Chemico-Biol Interact"},{"key":"10.1097\/MAJ.0b013e3180cab70a_bb0285","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0925-5710(97)00112-6","article-title":"Diagnostic and biological significance of sideroblastic erythropoiesis in the myelodysplastic syndromes","volume":"67","author":"Yoshida","year":"1998","journal-title":"Int J Hematol"},{"key":"10.1097\/MAJ.0b013e3180cab70a_bb0290","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJMoa041668","article-title":"Efficacy of Lenalidomide in myelodysplastic syndromes","volume":"352","author":"List","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1097\/MAJ.0b013e3180cab70a_bb0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijc.22719","article-title":"The non-Hodgkin lymphomas: A review of the epidemiologic literature","volume":"120","author":"Alexander","year":"2007","journal-title":"Int J Can"},{"key":"10.1097\/MAJ.0b013e3180cab70a_bb0300","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1182\/blood-2006-06-031948","article-title":"Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10211 cases and 11905 controls from the International Lymphoma Epidemiology Consortium (InterLymph)","volume":"109","author":"Wang","year":"2007","journal-title":"Blood"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962915324344?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962915324344?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T02:53:03Z","timestamp":1710125583000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962915324344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":59,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["S0002962915324344"],"URL":"https:\/\/doi.org\/10.1097\/maj.0b013e3180cab70a","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}